This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| European Congress of Immunology | |
|---|---|
| Name | European Congress of Immunology |
| Formation | 1987 |
| Type | Conference |
| Region served | Europe |
| Parent organization | European Federation of Immunological Societies |
European Congress of Immunology The European Congress of Immunology is a recurrent scientific conference organized by the European Federation of Immunological Societies that convenes immunologists from across Europe and worldwide. The congress assembles researchers, clinicians, industry representatives, and policy-makers to present advances in adaptive immunity, innate immunity, vaccinology, and translational immunology, fostering exchange among members of national societies such as the British Society for Immunology, Deutsche Gesellschaft für Immunologie, and Société Française d'Immunologie. Hosted in major European cities including Berlin, Barcelona, Dublin, and Vienna, the event parallels other global gatherings like the American Association of Immunologists meetings and the International Congress of Immunology.
The founding of the congress in the late 1980s followed initiatives by the European Federation of Immunological Societies and leaders from national bodies such as the British Society for Immunology and the Italian Society of Immunology, Clinical Immunology and Allergology to create a pan-European forum analogous to the American Association of Immunologists and the Japanese Society for Immunology. Early meetings featured keynote speakers connected to institutions like the Max Planck Society, Karolinska Institutet, Imperial College London, and the Pasteur Institute, and highlighted breakthroughs that later influenced work at centers such as Wellcome Trust, Francis Crick Institute, and European Molecular Biology Laboratory. Over the decades the congress expanded its scope to incorporate translational hubs including the European Commission-funded frameworks, collaborations with the European Medicines Agency, and partnerships with professional organizations like the European Society for Clinical Investigation.
The congress is administered under the auspices of the European Federation of Immunological Societies with oversight from elected committees drawn from member societies including the British Society for Immunology, German Society of Immunology, Swiss Society for Allergology and Immunology, and the Scandinavian Society for Immunology. Governance structures reflect practices seen in professional bodies such as the Royal Society, Academy of Medical Sciences (United Kingdom), and the European Science Foundation, and involve scientific program committees, local organizing committees drawn from host institutions like University College London, Universität Wien, Universitat de Barcelona, and liaison with agencies such as the European Research Council and national funding bodies like the Medical Research Council (United Kingdom).
Notable editions have been staged in cities with major research hubs: Berlin editions drew participants from the Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin; Barcelona meetings engaged groups from the Barcelona Institute for Global Health and Institut d'Investigacions Biomèdiques August Pi i Sunyer; the Dublin congress integrated researchers from Trinity College Dublin and University College Dublin. High-profile symposia have featured investigators affiliated with the National Institutes of Health, Wellcome Trust Sanger Institute, Institut Pasteur, and the European Molecular Biology Organization, and have showcased laureates associated with awards such as the Lasker Award, Nobel Prize, and the Gairdner Foundation International Award.
Programs typically encompass sessions on topics linked to institutions and advances: antigen receptor biology from groups at Massachusetts Institute of Technology and Stanford University interacting with European labs; tumor immunology with contributions from the European Society for Medical Oncology and cancer centers such as the Institute Gustave Roussy; immune tolerance and autoimmunity with speakers from Karolinska Institutet and the Hôpital Saint-Louis; infectious disease immunology with collaborations involving the World Health Organization and the European Centre for Disease Prevention and Control. Thematic tracks often reference methodologies and consortia like the Human Cell Atlas, ENCODE Project, Horizon Europe, and translational networks tied to the European Medicines Agency and biotechnology firms in the Cambridge Biomedical Campus and BioCity Nottingham.
The congress presents prizes and recognitions modeled on awards from bodies such as the European Molecular Biology Organization, Royal Society, and national academies including the Académie des sciences (France) and the Deutsche Forschungsgemeinschaft. Awards honor young investigators, lifetime achievement, and translational impact, comparable to distinctions like the Louis-Jeantet Prize for Medicine, EMBO Gold Medal, and national medals conferred by institutions such as the Royal College of Physicians and the Karolinska Institutet.
Attendees include delegates from national societies such as the British Society for Immunology, Deutsche Gesellschaft für Immunologie, Sociedad Española de Inmunología, and the Hellenic Society of Immunology as well as representatives from the European Commission, pharmaceutical companies like GlaxoSmithKline, Novartis, Roche, and biotechnology firms clustered in regions like Biotech Valley and Silicon Fen. Participation trends mirror those at meetings like the American Association of Immunologists annual meeting and the Federation of European Neuroscience Societies forums, with thousands of delegates including graduate students from universities such as University of Oxford, University of Cambridge, ETH Zurich, and postdoctoral fellows from research centers like the European Molecular Biology Laboratory.
The congress has facilitated collaborations that influenced projects funded by the European Research Council, Horizon 2020, and philanthropic organizations such as the Wellcome Trust and Gates Foundation. Scientific discourse at the congress has accelerated translational pipelines between academic groups at institutions like Institute Pasteur, Max Planck Institute for Infection Biology, and industry partners such as AstraZeneca and Sanofi, contributing to vaccine development efforts and immunotherapy advances recognized by prizes like the Nobel Prize in Physiology or Medicine and the Lasker Award. Networking at the congress has fostered multi-center trials coordinated with hospitals such as Charité – Universitätsmedizin Berlin and Hôpital Pitié-Salpêtrière, and shaped policy dialogues involving the European Medicines Agency, World Health Organization, and national health ministries.
Category:Immunology conferences